Indicated for closure of femoral artery punctures after interventional and diagnostic procedures
Automated collagen compaction and enhanced ease-of-use design; suture, collagen, and anchor sandwich of the arteriotomy; all components reabsorb within 60 to 90 days; FDA labeling for immediate restick; FDA labeling for 20-minute ambulation and 60-minute discharge for diagnostic cases with a 6-F sheath or smaller procedural sheath
Terumo Europe
Angio-Seal VIP Vascular Closure Device
Mechanical seal, fully bioabsorbable components
≤ 6, ≤ 8
0.035 (≤ 6 F), 0.038 (≤ 8 F)
Indicated for closure of femoral artery punctures after interventional and diagnostic procedures
Suture, collagen, and anchor sandwich of the arteriotomy; all components reabsorb within 60 to 90 days; FDA labeling for immediate restick; FDA labeling for 20-minute ambulation and 60-minute discharge for diagnostic cases with a 6-F sheath or smaller procedural sheath
Cordis
Cordis Exoseal Vascular Closure Device
Extravascular PGA plug
5, 6, 7
Utilizes existing procedural sheath
–
Precise extravascular positioning with unique lockout mechanism and visual indicators to help prevent intravascular deployment; the Exoseal vascular closure device does not require assembly and is deployed via a simple 3-step process; the PGA plug is fully resorbed as carbon dioxide and water within 60–90 days
Terumo Europe
FemoSeal Vascular Closure Device
Mechanical seal, fully bioabsorbable components
≤ 7
0.038
Indicated for closure of femoral artery punctures after interventional and diagnostic procedures
Suture and polymer discs sandwich of the arteriotomy; all components reabsorb within 90 days
Teleflex
Manta Vascular Closure Device
Bioresorbable implant
Following the use of 10–20 F device or sheaths (12–25 F OD)
0.035
The 14-F device is indicated for closure of femoral arterial access sites after the use of 10- to 14-F devices or sheaths (maximum OD/profile of 18 F), and the 18-F device is indicated for closure of femoral arterial access sites after the use of 15- to 18-F devices or sheaths (maximum OD/profile of 25 F)
Designed specifically for closure of large bore femoral artery access sites; easy positioning without the need for preclosure; simple deployment with help from auditory and visual cues and a reliable closure using a single device
Cordis
Mynx Ace Vascular Closure Device
Extravascular sealant
5, 6, 7
0.035
–
New, easy-to-use deployment system; Mynx Ace provides secure mechanical closure with the safety of an extravascular sealant; the Grip sealant actively adheres to and seals the arteriotomy while expanding to fill the tissue tract; Mynx Ace offers a closure option that is completely extravascular and dissolves within 30 days
Cordis
MynxGrip Vascular Closure Device
Extravascular sealant
5, 6, 7
Utilizes existing procedural sheath
–
Provides secure mechanical closure with the safety of an extravascular sealant; the Grip sealant actively adheres to and seals the arteriotomy or venotomy while expanding to fill the tissue tract; MynxGrip offers a closure option that is completely extravascular and dissolves within 30 days
Occlutech International AB
Occlutech Hubless PDA Occluder
Patent ductus arteriosus closure device
No puncture needed
0.038
Yes
Percutaneously implanted through a catheter intervention technique and intended for the nonsurgical occlusion of patent ductus arteriosus
Abbott
Perclose ProGlide
Suture
Common femoral artery 5–21 (max OD, 26); common femoral vein 5–24 (max OD, 29)
0.038
Common femoral artery (5–21 F) and vein (5–24 F) access sites
Provides secure repair with pretied polypropylene monofilament suture, ability to maintain wire access, minimal intravascular footprint with no reaccess restrictions; broadest indication for both femoral arterial and venous access
Abbott
Prostar XL
Suture
8.5–24
0.038
Common femoral artery access sites
Provides secure repair with two braided sutures, ability to maintain wire access with minimal intravascular footprint
Abbott
StarClose SE
Nitinol clip
5–6
0.038
Common femoral artery (5–6 F) access sites
Utilizes an extravascular nitinol clip to provide immediate repair, simple to use; hemostasis can be challenged and confirmed on the table
Haemonetics
Vascade MVP Venous Vascular Closure System (VVCS)
Extravascular, bioabsorbable closure device
6–12 inner diameter (up to 15 maximum outer diameter)
Utilizes existing procedural sheath
–
Fully integrated, extravascular, bioabsorbable femoral venous closure system that is easy to use, leaves no permanent components behind, and has demonstrated safety and efficacy in the AMBULATE trial, a prospective, multicenter, randomized clinical trial comparing Vascade MVP to manual compression; system combines Cardiva’s collapsible disc technology and a thrombogenic resorbable collagen patch in an integrated design
Haemonetics
Vascade Vascular Closure System (VCS)
Extravascular, bioabsorbable closure device
5, 6, 7
Utilizes existing procedural sheath
–
Fully integrated, extravascular, bioabsorbable femoral access closure system that is easy to use, leaves no permanent components behind, and has demonstrated safety and efficacy in the RESPECT trial, a prospective, multicenter, randomized clinical trial comparing Vascade to manual compression; system combines Cardiva’s collapsible disc technology and a thrombogenic resorbable collagen patch in an integrated design; it enables rapid hemostasis while minimizing complications
Advertisement
Advertisement
We value keeping the Device Guide up to date.
If you want to add or update your company’s device listings, please let us know!